Across TCGA pan-cancer cohorts, MIR26B RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated MIR26B data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher MIR26B RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR26B expression acts as an unfavorable survival marker, although some lineages such as MESO and SKCM show a favorable association.
UVM, COAD, and UCEC are the cancer types where MIR26B RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.